Companies
Public Gene-Editing Companies
Gene-editing companies with listed shares, as held in the Atlas.
So wird diese Liste erstellt
Companies in the Atlas that have shares traded on a public exchange. The Atlas does not carry share prices or market capitalisations — those change constantly, and a stale figure is worse than none.
| # | Eintrag | Kategorie | Status |
|---|---|---|---|
| 1 | CRISPR Therapeutics Co-founded by Emmanuelle Charpentier, and the company behind the first approved CRISPR… | CRISPR-Cas9 platform | Approved |
| 2 | Intellia Therapeutics Co-founded by Jennifer Doudna, and the company that first delivered CRISPR into a human… | In vivo CRISPR platform | Phase III |
| 3 | Beam Therapeutics Founded by David Liu and colleagues to commercialise base editing — precision changes to… | Base editing platform | Phase III |
| 4 | Editas Medicine One of the first CRISPR companies, which discontinued its cell-therapy and eye programmes… | In vivo editing | Preclinical |
| 5 | Prime Medicine Founded to commercialise prime editing, and the company behind the first published… | Prime editing platform | Phase I/II |
| 6 | Verve Therapeutics Built to turn heart disease into a one-time treatment, and acquired by Eli Lilly in 2025… | In vivo base editing | Phase II |
| 7 | Caribou Biosciences Co-founded by Jennifer Doudna, using hybrid RNA-DNA guides intended to make editing… | Cell therapy | Phase I |
| 8 | Sana Biotechnology Engineering transplanted cells to be invisible to the immune system, so they can be given… | Cell engineering | Phase I |
| 9 | Scribe Therapeutics Co-founded by Jennifer Doudna to engineer CRISPR enzymes from scratch rather than use the… | Engineered editors | Preclinical |
| 10 | Mammoth Biosciences Co-founded by Jennifer Doudna around ultra-compact CRISPR proteins small enough to fit… | Miniature editors and diagnostics | Preclinical |
| 11 | Arbor Biotechnologies Co-founded by Feng Zhang and David Scott to discover new editing enzymes from nature at… | Novel editors | Phase I |
| 12 | Vertex Pharmaceuticals The established biotechnology company that partnered on, and commercialises, the first… | Large biotechnology | Approved |
| 13 | bluebird bio A pioneer of lentiviral gene addition with several approved therapies — and a cautionary… | Gene addition | Approved |
| 14 | Tessera Therapeutics Developing 'gene writing' — mobile genetic elements repurposed to insert whole sequences… | Gene writing | Preclinical |
| 15 | Tune Therapeutics Turning genes up and down without changing sequence — epigenetic editing taken into early… | Epigenetic editing | Phase I |
| 16 | Sangamo Therapeutics The company that took gene editing into humans first, years before CRISPR existed as a… | Zinc finger platform | Phase III |
| 17 | Eli Lilly and Company A major pharmaceutical company that entered gene editing by acquisition, buying Verve… | Large pharmaceutical | Phase II |
Was diese Liste dir nicht sagtEducational information only, not investment advice, and not a complete list of listed gene-editing companies. Nothing here is a recommendation regarding any security.